Press release
Diagnostic Specialty Antibodies Market Size, Share, Report 2024-2033
Diagnostic Specialty Antibodies
The Business Research Company presents an extensive market research report on the Diagnostic Specialty Antibodies Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.
Market Sizing:
The diagnostic specialty antibodies market size has grown strongly in recent years. It will grow from $28.33 billion in 2023 to $29.97 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to advancements in biotechnology, emergence of personalized medicine, increased disease understanding, immunoassay and diagnostic techniques, rise of companion diagnostics.
The diagnostic specialty antibodies market size is expected to see strong growth in the next few years. It will grow to $37.75 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to expanding disease biomarkers, rapid point-of-care testing, emerging infectious diseases, biosimilar and generic development, ai and machine learning integration. Major trends in the forecast period include technological advancements in assay development, integration of nanotechnology, enhanced specificity and selectivity, integration with wearable devices, continuous assay miniaturization.
Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12241&type=smp
Key Market Players:
Major companies operating in the diagnostic specialty antibodies market report are F. Hoffmann-La Roche AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Boehringer Ingelheim International GmbH, Merck KGaA, Becton Dickinson and Company, Regeneron Pharmaceuticals Inc, Agilent Technologies Inc., Sartorius AG, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., STEMCELL Technologies Inc., Abcam PLC, Telix Pharmaceuticals Limited, Aytu BioScience Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Creative Diagnostics, Novus Biologicals LLC, Confo Therapeutics SA, Precirix NV, Creative Biolabs Inc., Polymun Scientific ImmunbiologischeForschung GmbH.
Market Drivers:
The growing patient pool for HIV diagnosis is expected to propel the growth of the diagnostic specialty antibodies market going forward. The growing patient pool of HIV diagnoses refers to an increasing number of individuals who are being diagnosed with HIV (Human Immunodeficiency Virus). As the number of individuals being diagnosed with HIV increases, the market for diagnostic specialty antibodies expands, creating opportunities for manufacturers to develop and supply specialized antibody-based diagnostic products for HIV testing, enabling the detection of specific biomarkers associated with the virus and aiding in the early detection and monitoring of HIV infection. For instance, in July 2022, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS), the Switzerland-based UN program dedicated to addressing the global HIV or AIDS epidemic, the global population living with HIV increased by 1.6% from 37.8 million in 2020 to 38.4 million in 2021. Further, there were approximately 1.5 million new HIV infections reported in 2021. Therefore, the growing patient pool of HIV diagnoses is driving the growth of the diagnostic specialty antibodies market.
Learn More About The Market Report -
https://www.thebusinessresearchcompany.com/report/diagnostic-specialty-antibodies-global-market-report
The diagnostic specialty antibodies market covered in this report is segmented -
1) By Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies
2) By Application: Hepatitis, Tuberculosis, Dengue, Oncology, Human Immunodeficiency Virus (HIV), Infectious Disease, Other Applications
3) By End User: Diagnostic Laboratories, Hospitals
The report answers the following questions:
What are the primary factors propelling the market during the projected period?
In which region is the most substantial growth expected?
Which trend will take center stage in the upcoming period?
Want To Know More About The Business Research Company?
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diagnostic Specialty Antibodies Market Size, Share, Report 2024-2033 here
News-ID: 3380293 • Views: …
More Releases from The Buisness Research Company
Organic Period Care Products Market Anticipated To Witness Robust Growth, Surpas …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Organic Period Care Products Market Size and Its Estimated Growth Rate?
The size of the market for organic period care products has significantly expanded in recent years, and it's projected to escalate from $2.63 billion in 2024 to $2.83 billion in 2025, with a compound annual growth rate…
Porous Ceramics Market 2024: Trends, Industry Insights, and Growth Drivers
The Business Research Company recently released a comprehensive report on the Global Porous Ceramics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
AI in Automotive & Transportation Market 2024: Key Trends and Growth Outlook
The Business Research Company recently released a comprehensive report on the Global AI In Automotive And Transportation Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The …
Anosmia Global Market 2024 Strategic Outlook Emerging Trends and Market Forecast
The new report published by The Business Research Company, titled Anosmia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the anosmia market size has grown strongly in recent years. It will grow from $3.24 billion in 2023 to $3.55…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
